Detalles de la búsqueda
1.
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist
; 28(2): 157-164, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200791
2.
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
J Urol
; 208(1): 71-79, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35212574
3.
Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction.
BJU Int
; 129(3): 364-372, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780097
4.
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Oncologist
; 24(11): 1416-1419, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444293
5.
Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Future Oncol
; 14(14): 1409-1421, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848096
6.
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy.
Eur Urol Oncol
; 6(4): 431-436, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35792045
7.
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.
Urol Oncol
; 40(10): 454.e9-454.e16, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788287
8.
Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
Front Oncol
; 11: 674782, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34026652
9.
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Eur Urol Oncol
; 3(4): 544-547, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32165095
10.
Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
Front Oncol
; 8: 652, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705875
11.
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.
Eur Urol Oncol
; 1(1): 54-60, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420974
Resultados
1 -
11
de 11
1
Próxima >
>>